Fevola, C.
Dolce, D.
Tosco, A.
Padoan, R.
Daccò, V.
Claut, L.
Schgor, T.
Sepe, A.
Timpano, S.
Fabrizzi, B.
Piccinini, P.
Taccetti, G.
Bonomi, P.
Terlizzi, V.
Article History
Received: 13 September 2023
Revised: 27 November 2023
Accepted: 29 November 2023
First Online: 6 December 2023
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Regional Ethics Committee for Clinical Trials of the Tuscany Region AOU Meyer-Viale Pieraccini, 24-50139 Florence (Ethics Clearance numbers 140/2018 on 01/10/2018, and 235/2020 on 05/10/2020) and subsequently by all ethical committees of the participating CF centres.
: Informed consent was obtained from all subjects involved in the study.
: The authors declare no competing interests.